Youth marijuana use does not increase after states enact legalization for medical or recreational use, researchers concluded in a study published in a prominent scientific journal on Tuesday. The policy change instead has an overall impact on adolescent cannabis consumption that is “statistically indistinguishable from zero,” they found.

Federal courts representing the U.S. territories of Guam and the Commonwealth of the Northern Mariana Islands (CNMI) will be hosting a seminar next week on marijuana legalization and its potential impact on the tourism industry.

Both territories have moved to legalize cannabis for adult use in recent years, and now their U.S. district courts are holding a seminar titled “Marijuana Hits the Shores of Guam and CNMI” on September 17.

A new ruling in a federal trademarking case for a CBD beverage company underscores how the Food and Drug Administration’s (FDA) slow-walking of rules for certain hemp-derived products is creating headaches for the burgeoning industry.

A company that sells CBD-infused teas submitted an “intent to use” trademark application but was denied by the U.S. Patent and Trademark Office (USPTO) in May—and that decision was reaffirmed by an appeals board last week.

At least ten of the 36 craft grow licenses awarded last month by the State of Illinois have gone to groups affiliated with existing cannabis companies, while some others went to current local politicians and a smattering of local notables.

A federal judge has blocked a Northern California county’s ban on trucks delivering water to Hmong cannabis farmers, saying it raises “serious questions” about racial discrimination and leaves the growers without a source of water for basic sanitation, vegetable gardens and livestock.

On Friday, Chief U.S. District Judge Kimberly J. Mueller issued a temporary injunction against Siskiyou County’s prohibition on trucked-in water deliveries to Hmong farmers growing marijuana in the Mount Shasta Vista subdivision in the Big Springs area north of Weed.

Sajid Javid has been urged to ‘finish the job’ of making medical cannabis more accessible on the NHS.
The Health Secretary announced in 2018, when he was Home Secretary, that the law would change to allow GPs to prescribe the drug, which can be used to treat children with rare forms of epilepsy.

Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions

Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic non-cancer pain. Currently, the pharmacotherapeutic options against CMP are limited and frequently consist of pain management with non-steroidal anti-inflammatories, gabapentinoids, or opioids, which carry major adverse effects. Although the effectiveness of medical cannabis (MC) for CMP still lacks solid evidence, several patients suffering from it are exploring this therapeutic option with their physicians.

source